Key Points of the Study:
T-TEER with the TriClip device significantly improved health status in patients with severe tricuspid regurgitation (TR) compared to medical therapy alone.
This improvement was seen in both the short-term (1 month) and long-term (1 year) after the procedure.
T-TEER patients were more likely to be alive and well (defined as good KCCQ score and no decline) at 1 year compared to those on medical therapy.
The benefit of T-TEER was greater for patients with lower baseline health scores (KCCQ).
The health status improvement after T-TEER was likely due to reduced TR and correlated with reduced mortality and heart failure hospitalizations.
In conclusion, T-TEER is a promising treatment for severe TR, leading to significant and sustained improvement in health status and quality of life for patients.
Link to article: